期刊文献+

激动素对AlCl_3和D-半乳糖联合诱导的AD小鼠模型大脑病理变化和Aβ表达的影响 被引量:5

Effects of Kinetin on Pathological Lesions and Aβ Expression in Brain of AD Mouse Model Induced by AlCl_3 and D-galactose Combination Treatment
下载PDF
导出
摘要 旨在研究激动素对AD小鼠模型的神经保护作用。首先用AlCl_3和D-半乳糖联合处理制备AD小鼠模型,然后用不同浓度的激动素进行干预处理,再通过HE染色对大脑海马CA3区进行病理学观察,并对大脑皮层和海马部位β淀粉样蛋白(βamyloid protein,Aβ)进行免疫组化染色。结果表明,AlCl_3和D-半乳糖处理过的小鼠其海马CA3区锥体细胞发生明显的病理变化,而激动素的干预减轻了这一病变,且表现出剂量依赖性。同时,AlCl_3和D-半乳糖处理过的小鼠与空白组小鼠相比,大脑皮层和海马区Aβ1-42分布均显著增加,但激动素干预能够使Aβ1-42的表达和分布明显减少,且显示出剂量依赖性的特点。这些结果说明激动素对AD小鼠模型具有一定的正向干预作用,表明激动素可能具有抗AD的潜力。 The aim of this study was to investigate the neuroprotective effects of kinetin on AD mouse models.The AD mouse models were prepared by AlCl3 and D-galactose,and at the same time were treated with different concentrations of kinetin.The hippocampal CA3 region was observed by HE staining.Immunohistochemical staining of β amyloid protein (A;) in the cortex and hippocampus was also performed.The results showed that the pyramidal cells in the hippocampal CA3 region of the mice treated with AlCl3 and Dgalactose had a significant pathological change, but the intervention of kinetin reduced the lesion. At the same time,the distribution of Aβ1-42 in cortex and hippocampus was significantly increased compared with the blank group,but that in kinetin intervention group was significantly decreased.All the results showd ki- netin dose-dependent characteristics. These results indicated that kinetin has some positive effects on AD mouse models,and may has the potential to fight AD.
出处 《动物医学进展》 北大核心 2017年第12期68-72,共5页 Progress In Veterinary Medicine
基金 陕西省重大科技创新专项基金(K332020916)
关键词 激动素 三氯化铝 D-半乳糖 病理变化 kinetin AlCl3 D-galactose pathological lesion
  • 相关文献

参考文献2

二级参考文献16

  • 1Chiocco MJ,Kulnane LS,Younkin L. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice[J].Journal of Biological Chemistry,2004,(50):52535-52542. 被引量:1
  • 2Saido TC,Iwata N. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease.Towards presymptomatic diagnosis,prevention and therapy[J].Neuroscience Research,2006,(04):235-253.doi:10.1016/j.neures.2005.12.015. 被引量:1
  • 3Farris W,Mansourian S,Chang Y. Insulin-degrading enzyme regulates the levels of insulin,amyloid beta-protein,and the betaamyloid precursor protein intracellular domain in vivo[J].Proceedings of the National Academy of Sciences(USA),2003,(07):4162-4167. 被引量:1
  • 4Farris W,Mansourian S,Leissring MA. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein[J].American Journal of Pathology,2004,(04):1425-1434. 被引量:1
  • 5Tanzi RE,Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis:a genetic perspective[J].Cell,2005,(04):545-555.doi:10.1016/j.cell.2005.02.008. 被引量:1
  • 6Hardy J,Selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics[J].Science,2002,(5580):353-356. 被引量:1
  • 7Ohno M,Cole SL,Yasvoina M. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice[J].Neurobiology of Disease,2007,(01):134-145. 被引量:1
  • 8McConlogue L,Buttini M,Anderson JP. Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice[J].Journal of Biological Chemistry,2007,(36):26326-26334. 被引量:1
  • 9Fukumoto H,Cheung BS,Hyman BT. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease[J].Archives of Neurology,2002,(09):1381-1389.doi:10.1001/archneur.59.9.1381. 被引量:1
  • 10Tyler SJ,Dawbarn D,Wilcock GK. alpha-and betasecretase:profound changes in Alzheimer's disease[J].Biochemical and Biophysical Research Communications,2002,(03):373-376. 被引量:1

共引文献51

同被引文献53

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部